Real-world impact of latanoprostene bunod ophthalmic solution 0.024% in glaucoma therapy: a narrative review by W. Daniel Stamer, Thomas Chiu, Da-Wen Lu, Tsing Hong Wang, Prin Rojanapongpun, Ngamkae Ruangvaravate, Youn Hye Jo, Marlene R. Moster, Marlene R. Moster, Murray Fingeret, Nora Lee Cothran, Jessica Steen, Ian Benjamin Gaddie, Ömür Uçakhan-Gündüz, Wesam Shamseldin Shalaby, Wesam Shamseldin Shalaby, Cindy M. L. Hutnik

Get full text